Soligenix, Inc. (SNGX) stock
SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.28−0.01 (-2.67%)
Close on Nov 17, 2026Market cap $6.11MP/E –Yield –
Soligenix total assets
Total assets on the balance sheet at the end of each period.
Soligenix's total assets was $10.50M at Jun 30, 2026. For fiscal 2025 it was $9.24M, up 3.0% from the year before. Over ten years it grew 2.3% a year on average. The highest annual figure on record is $26.87M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.24M | +3.0% |
| FY2024 | Dec 31, 2024 | $8.97M | -8.5% |
| FY2023 | Dec 31, 2023 | $9.80M | -31.4% |
| FY2022 | Dec 31, 2022 | $14.28M | -46.9% |
| FY2021 | Dec 31, 2021 | $26.87M | +35.1% |
| FY2020 | Dec 31, 2020 | $19.89M | +155.8% |
| FY2019 | Dec 31, 2019 | $7.78M | -25.9% |
| FY2018 | Dec 31, 2018 | $10.49M | +9.9% |
| FY2017 | Dec 31, 2017 | $9.55M | -7.0% |
| FY2016 | Dec 31, 2016 | $10.27M | +39.0% |
| FY2015 | Dec 31, 2015 | $7.39M | +6.2% |
| FY2014 | Dec 31, 2014 | $6.95M | -15.9% |
| FY2013 | Dec 31, 2013 | $8.27M | +75.7% |
| FY2012 | Dec 31, 2012 | $4.71M | -42.8% |
| FY2011 | Dec 31, 2011 | $8.22M | -11.3% |
| FY2010 | Dec 31, 2010 | $9.27M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $10.50M | +82.3% |
| Q1 FY2026 | Mar 31, 2026 | $6.92M | -10.6% |
| Q4 FY2025 | Dec 31, 2025 | $9.24M | +3.0% |
| Q3 FY2025 | Sep 30, 2025 | $11.29M | +7.8% |
| Q2 FY2025 | Jun 30, 2025 | $5.76M | -41.6% |
| Q1 FY2025 | Mar 31, 2025 | $7.75M | -3.9% |
| Q4 FY2024 | Dec 31, 2024 | $8.97M | -8.5% |
| Q3 FY2024 | Sep 30, 2024 | $10.48M | -7.3% |
| Q2 FY2024 | Jun 30, 2024 | $9.87M | -28.6% |
| Q1 FY2024 | Mar 31, 2024 | $8.06M | -27.4% |
| Q4 FY2023 | Dec 31, 2023 | $9.80M | -31.4% |
| Q3 FY2023 | Sep 30, 2023 | $11.30M | -37.0% |
| Q2 FY2023 | Jun 30, 2023 | $13.83M | -35.1% |
| Q1 FY2023 | Mar 31, 2023 | $11.10M | -53.1% |
| Q4 FY2022 | Dec 31, 2022 | $14.28M | -46.9% |
| Q3 FY2022 | Sep 30, 2022 | $17.95M | -39.6% |
| Q2 FY2022 | Jun 30, 2022 | $21.31M | -28.0% |
| Q1 FY2022 | Mar 31, 2022 | $23.67M | -25.0% |
| Q4 FY2021 | Dec 31, 2021 | $26.87M | +35.1% |
| Q3 FY2021 | Sep 30, 2021 | $29.72M | +124.3% |
| Q2 FY2021 | Jun 30, 2021 | $29.61M | +141.5% |
| Q1 FY2021 | Mar 31, 2021 | $31.55M | +220.4% |
| Q4 FY2020 | Dec 31, 2020 | $19.89M | +155.8% |
| Q3 FY2020 | Sep 30, 2020 | $13.25M | +39.2% |
| Q2 FY2020 | Jun 30, 2020 | $12.26M | +16.9% |
| Q1 FY2020 | Mar 31, 2020 | $9.85M | -25.9% |
| Q4 FY2019 | Dec 31, 2019 | $7.78M | +26.4% |
| Q1 FY2019 | Mar 31, 2019 | $9.52M | +27.3% |
| Q4 FY2018 | Dec 31, 2018 | $10.49M | +9.9% |
| Q3 FY2018 | Sep 30, 2018 | $13.29M | +127.1% |
| Q2 FY2018 | Jun 30, 2018 | $6.15M | -9.2% |
| Q1 FY2018 | Mar 31, 2018 | $7.48M | -11.1% |
| Q4 FY2017 | Dec 31, 2017 | $9.55M | -7.0% |
| Q3 FY2017 | Sep 30, 2017 | $5.85M | -24.5% |
| Q2 FY2017 | Jun 30, 2017 | $6.77M | +25.1% |
| Q1 FY2017 | Mar 31, 2017 | $8.41M | +50.4% |
| Q4 FY2016 | Dec 31, 2016 | $10.27M | – |
| Q3 FY2016 | Sep 30, 2016 | $7.75M | – |
| Q2 FY2016 | Jun 30, 2016 | $5.42M | – |
| Q1 FY2016 | Mar 31, 2016 | $5.59M | – |
See a number that looks wrong?